41.3
Les Cellules Souches Mésenchymateuses
View the full transcript and gain access to JoVE Core videos
Q1: What are mesenchymal stem cells and where do they originate?
Mesenchymal stem cells (MSCs) are multipotent stem cells originating from the embryonic ectoderm and mesoderm. They arise as epithelial cells from the epiblast, the developing embryo's outermost layer, then migrate inward and laterally. MSCs can differentiate into multiple connective tissue cell types and share similar morphology and gene expression with fibroblasts.
Q2: How does the extracellular matrix influence MSC differentiation?
MSC differentiation depends on the mechanical properties of the extracellular matrix. On soft matrices, MSCs differentiate into adipocytes; on harder matrices, they differentiate into osteoblasts that form bone matrix. This matrix-dependent differentiation is crucial for proper tissue formation and regeneration.
Q3: What is the epithelial-to-mesenchymal transition and why is it important?
The epithelial-to-mesenchymal transition is the process where epithelial cells from the epiblast transform into mesenchymal stem cells and migrate to form various tissues. This transition is essential for proper organ and tissue formation during embryonic development and enables MSCs to reach their target locations.
Q4: Where can mesenchymal stem cells be isolated from in adults?
Adult MSCs can be isolated from various sources including bone marrow, placenta, adipose tissue, teeth, and Wharton's jelly in the umbilical cord. Bone-marrow-derived MSCs can differentiate into osteocytes, hepatocytes, pancreatic cells, and neuronal cells. Their accessibility and stability make them valuable for regenerative medicine applications.
Q5: How do extracellular vesicles from MSCs support immunomodulation?
Extracellular vesicles (EVs) released from MSCs facilitate immunomodulation by carrying nucleic acids, proteins, and paracrine signaling molecules to recipient cells. EVs can cross the blood-brain barrier and effectively trigger immune responses, making MSCs and EVs candidates for treating autoimmune disorders like rheumatoid arthritis.
Q6: What are the dual roles of MSCs in cancer treatment?
MSCs exhibit contradictory effects in cancer: they can promote tumor growth by secreting growth factors that induce angiogenesis and facilitate invasion. However, MSCs also inhibit tumor cell cycle pathways and release cytotoxic factors to trigger programmed cell death. This dual nature makes MSCs a 'double-edged sword' in cancer therapy.
Q7: How do MSCs compare to fibroblasts in structure and function?
MSCs are similar to fibroblasts in morphology, gene expression, and differentiation potential. Both cell types originate from mesenchymal tissues and can differentiate into various connective tissue cell types. Understanding their similarities helps clarify MSC behavior and their role in tissue repair and regeneration.